Effects of quercetin on ovarian function and regulation of the ovarian PI3K/Akt/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide‐induced premature ovarian failure
Abstract:To investigate the ability of quercetin to improve ovarian function and inhibit ovarian oxidative stress through the PI3K/Akt/FoxO3a signalling pathway in a rat model of premature ovarian failure (POF), we constructed a POF rat model with cyclophosphamide (CTX) and treated it with quercetin. Haematoxylin and eosin staining (H&E staining) was used to observe the morphological changes of the ovaries. The serum levels of AMH, E2, FSH, SOD, GSH‐Px and MDA were determined by enzyme‐linked immunosorbent assays. The … Show more
“…Its main function is to maintain the function of the female reproductive system and the secretion of hormones [ 23 ]. The imbalance of free radical metabolism caused by endemic fluorosis and the damage of organ function caused by the accumulation of a large number of oxidative stress products have always been a hot issue for researchers [ 23 ]. Oxidative stress injury will promote the production of inflammatory factors [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…NLRP3 can promote the secretion of proinflammatory cytokines, aggravate cell damage, and induce cell death [32,33]. Inhibiting NLRP3 inflammatory signal can reduce inflammatory response and protect tissues, promote the release of anti-inflammatory cytokine IL-10 and proinflammatory cytokine IL-21 levels in serum, improve the inflammatory response of ovary, and reduce the inflammatory injury of follicle and the decline of ovarian reserve function [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]. This study showed that the HUCMSCs suppressed NOX4, NLRP3, and GSDMD protein expression levels in the in vitro model.…”
Premature ovarian failure refers to a series of symptoms of perimenopausal hot flashes, night sweats, decreased libido, vaginal dryness, insomnia, reduced menstruation, sparse hair, even amenorrhea, and even infertility before the age of 40 due to the decline of ovarian function. Premature ovarian failure is a common and difficult disease in gynecology. Its prevalence is increasing gradually, and the trend is younger. The aim of this experiment was to elucidate the role of human umbilical cord mesenchymal stem cells (HUCMSCs) in premature ovarian failure and its mechanism. HUCMSCs, KGN cells, and HEK293T cells were used in this experiment. Quantitative PCR and microarray analysis, ELISA inflammation and oxidative stress kits, RNA pull-down assay, luciferase reporter assay, proliferation assay, EDU staining, and Western blot analysis were used. In an in vitro model of premature ovarian failure, HUCMSCs attenuated inflammatory response, oxidative stress, and apoptosis. HUCMSCs ameliorated the premature ovarian failure model. The miR-100-5p expression was induced by HUCMSCs through methylation. miR-100-5p regulation influenced the role of HUCMSCs in an in vitro model of premature ovarian failure. HUCMSCs inhibited the in vitro expression of NOX4, NLRP3, and GSDMD proteins in the model. NOX4/NLRP3 signaling pathway affects the role of HUCMSCs in an in vitro model of premature ovarian failure through miR-100-5p. This experiment elucidated the role of HUCMSCs in premature ovarian failure and its mechanism, with a view to providing a clinical reference.
“…Its main function is to maintain the function of the female reproductive system and the secretion of hormones [ 23 ]. The imbalance of free radical metabolism caused by endemic fluorosis and the damage of organ function caused by the accumulation of a large number of oxidative stress products have always been a hot issue for researchers [ 23 ]. Oxidative stress injury will promote the production of inflammatory factors [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…NLRP3 can promote the secretion of proinflammatory cytokines, aggravate cell damage, and induce cell death [32,33]. Inhibiting NLRP3 inflammatory signal can reduce inflammatory response and protect tissues, promote the release of anti-inflammatory cytokine IL-10 and proinflammatory cytokine IL-21 levels in serum, improve the inflammatory response of ovary, and reduce the inflammatory injury of follicle and the decline of ovarian reserve function [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]. This study showed that the HUCMSCs suppressed NOX4, NLRP3, and GSDMD protein expression levels in the in vitro model.…”
Premature ovarian failure refers to a series of symptoms of perimenopausal hot flashes, night sweats, decreased libido, vaginal dryness, insomnia, reduced menstruation, sparse hair, even amenorrhea, and even infertility before the age of 40 due to the decline of ovarian function. Premature ovarian failure is a common and difficult disease in gynecology. Its prevalence is increasing gradually, and the trend is younger. The aim of this experiment was to elucidate the role of human umbilical cord mesenchymal stem cells (HUCMSCs) in premature ovarian failure and its mechanism. HUCMSCs, KGN cells, and HEK293T cells were used in this experiment. Quantitative PCR and microarray analysis, ELISA inflammation and oxidative stress kits, RNA pull-down assay, luciferase reporter assay, proliferation assay, EDU staining, and Western blot analysis were used. In an in vitro model of premature ovarian failure, HUCMSCs attenuated inflammatory response, oxidative stress, and apoptosis. HUCMSCs ameliorated the premature ovarian failure model. The miR-100-5p expression was induced by HUCMSCs through methylation. miR-100-5p regulation influenced the role of HUCMSCs in an in vitro model of premature ovarian failure. HUCMSCs inhibited the in vitro expression of NOX4, NLRP3, and GSDMD proteins in the model. NOX4/NLRP3 signaling pathway affects the role of HUCMSCs in an in vitro model of premature ovarian failure through miR-100-5p. This experiment elucidated the role of HUCMSCs in premature ovarian failure and its mechanism, with a view to providing a clinical reference.
“…After carefully reviewing the full-text review ,13 studies were excluded due to the discrepancy of inclusion and exclusion criteria mentioned above. 14 studies [9][10][11][12][13][14][15][16][17][18][19][20][21][22] were nally selected for meta-analysis. A PRISMA ow diagram describing the process of literature search and selection is presented in Fig.…”
IntroductionCyclophosphamide (CTX), is reported to be extensively used to establish POI animal model. But the most effective dose has not been systematically concluded yet. This systematic review and network meta-analysis is aimed to compare and rank the different doses of cyclophosphamide in the CTX-induced POI rat model.MethodsRandomized controlled trials of CTX-induced rat POI model were searched in four databases from inception to December, 2021. A network meta-analysis was conducted to analyze the data of included publications. The quality assessment was assessed by SYRCLE’s risk of bias tool. Data were analyzed with STATA 15.0 and Review Manager 5.3.Result205 records were searched and a total of 14 articles met inclusion criteria, Compared by Ovarian morphological changes, estrous cycle and hormone level (FSH, E2, AMH), the loading dose of 200mg/kg CTX with the maintenance dose of 8mg/kg CTX for consecutive 14 days showed the best efficacy in inducing rat POI model.
“…Furthermore, quercetin is also a class of flavonoid natural compounds with anti-inflammatory, antioxidant, anti-obesity and anti-cancer properties. Studies have shown that quercetin can intervene in the development of PCOS, EMs and POI in a multi-targeted and multi-pathway manner (Park et al, 2019;Chen et al, 2022;Zheng et al, 2022), while quercetin supplementation significantly increased the relative abundance of Akkermansia and reduced the ratio of F/B in obese mice (Tan et al, 2021), improved LPS-induced inflammatory damage (Bian et al, 2018), maintained glucolipid metabolic and promoting the production of SCFAs to enhance insulin sensitivity and improve the inflammatory response. Therefore, we hypothesize that quercetin may ameliorate reproductive endocrine disorders by reshaping the structure of the intestinal flora and increasing the content of SCFAs.…”
Section: Active Ingredients Of Chinese Herbal Medicinesmentioning
As an important part of the human intestinal microecology, the intestinal flora is involved in a number of physiological functions of the host. Several studies have shown that imbalance of intestinal flora and its regulation of the intestinal barrier, intestinal immune response, and intestinal flora metabolites (short-chain fatty acids and bile acids) can affect the development and regression of female reproductive disorders. Herbal medicine has unique advantages in the treatment of female reproductive disorders such as polycystic ovary syndrome, endometriosis and premature ovarian insufficiency, although its mechanism of action is still unclear. Therefore, based on the role of intestinal flora in the occurrence and development of female reproduction-related diseases, the progress of research on the diversity, structure and composition of intestinal flora and its metabolites regulated by botanical drugs, Chinese herbal formulas and active ingredients of Chinese herbal medicines is reviewed, with a view to providing reference for the research on the mechanism of action of Chinese herbal medicines in the treatment of female reproductive disorders and further development of new herbal medicines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.